Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rethink Impact is the largest U.S.-based venture capital firm dedicated to investing in female and non-binary leaders leveraging technology in health, education, environmental sustainability, economic empowerment, climate tech, fintech for good, and future of work. They typically invest $2M-$10M in Late Seed to Series C rounds and have raised over $500M across their funds.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rethink Impact.